Michael McClure, MD
Plastic and Reconstructive Surgery · Orlando, FLNPI 1093891400
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,887 of the $14,529 with a category attached, or 88.7%. AbbVie accounts for 94.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $12,950 and has fallen 98.1% since, to $252 in 2025.
Across 25 payments — averaging $581.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Galderma Laboratories, L.p.$228
- Integra Lifesciences Corporation$173
- Avita Medical Americas, LLC$132
- Sientra, Inc.$124
- Medtronic$85
What the payments were for
- Consulting fees$851%
- Speaking & faculty fees$12,88789%
- Food & beverage$1,55711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $13,787 |
| Galderma Laboratories, L.p. | 6 | $228 |
| Integra Lifesciences Corporation | 1 | $173 |
| Avita Medical Americas, LLC | 1 | $132 |
| Sientra, Inc. | 1 | $124 |
| Medtronic | 2 | $85 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,529 in reported general payments places this provider in the 80th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $435 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Orlando
- John ChoiOrlando$45K
- Adam OppenheimerOrlando$38K
- Kenneth LeeOrlando$32K
- Omar BeidasOrlando$29K
- Vincent ChavanonOrlando$21K
- Sabrina PavriOrlando$16K
- George PopeOrlando$13K
- Jurij KieferOrlando$9K
- Alan DurkinVero Beach$548K
- Edgar SosaVero Beach$504K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.